Fennec Pharmaceuticals (FENC) Other Operating Expenses (2016 - 2025)

Fennec Pharmaceuticals (FENC) has 5 years of Other Operating Expenses data on file, last reported at $7.9 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses rose 70.6% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $22.4 million (up 3.57% YoY), and the FY2025 full-year result was $22.4 million, up 3.56% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $7.9 million, up from $5.9 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $7.9 million in Q4 2025 and bottomed at -$10.0 million in Q2 2022.
• The 4-year median for Other Operating Expenses is $4.6 million (2023), against an average of $3.6 million.
• The widest annual swing landed in 2023, when Other Operating Expenses surged 124.84%; it then slumped 42.35% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at $2.8 million in 2022, then jumped by 63.48% to $4.6 million in 2023, then climbed by 1.32% to $4.6 million in 2024, then jumped by 70.6% to $7.9 million in 2025.
• The last three Other Operating Expenses figures came in at $7.9 million (Q4 2025), $5.9 million (Q3 2025), and $5.3 million (Q2 2025), per Business Quant data.

Peer Comparison